Log In
Print this Print this

Pyroglutamate-3 beta amyloid mAb

  Manage Alerts
Collapse Summary General Information
Company Probiodrug AG
DescriptionIgG 2A isoform of a pyroglutamate-3 beta amyloid mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today